Tackling Pharmaceutical Pollution Along the Product Lifecycle: Roles and Responsibilities for Producers, Regulators and Prescribers DOI Creative Commons
Gillian Parker, Fiona A. Miller

Pharmacy, Journal Year: 2024, Volume and Issue: 12(6), P. 173 - 173

Published: Nov. 22, 2024

Pharmaceuticals produce considerable environmental harm. The industry’s resource-intensive nature, coupled with high energy costs for manufacturing and transportation, contribute to the “upstream” harms from greenhouse gas emissions ecosystem pollution, while factors such as overprescription, overuse, pharmaceutical waste “downstream” harms. Effectively addressing pollution requires an understanding of key roles responsibilities along product lifecycle. In this commentary, we argue that three actors—producers, regulators, prescribers—have unique interdependent address these issues. Producers market access regulators are upstream actors who can manage mitigate by both shifting manufacturing, business practices, regulatory requirements producing transparent, robust data on By contrast, prescribers downstream whose capacity reduce arises principally a “co-benefit” reducing inappropriate prescribing overuse. Potentially complicating prescriber’s role calls recommend “environmentally preferable medicines”. These continue increase, even sparsity transparent impact pharmaceuticals environment. Recognizing interdependencies among actors, that, rather than being ineffectual, draw needed attention critical responsibility prioritize production, reporting standards public transparency facilitate future efforts tackle pollution.

Language: Английский

Effects of Climate Change on Health and Health Systems: A Systematic Review of Preparedness, Resilience, and Challenges DOI Open Access

Vasileios Gkouliaveras,

Stavros Kalogiannidis, Dimitrios Kalfas

et al.

International Journal of Environmental Research and Public Health, Journal Year: 2025, Volume and Issue: 22(2), P. 232 - 232

Published: Feb. 6, 2025

Climate change has a significant impact on the population’s health and negatively affects functioning of healthcare systems. Health systems must be operationally prepared to handle challenges posed by environmental change. Resilience is required adapt quickly critical conditions reduce carbon emissions. In this systematic review strategies, for system preparedness resilience are examined address impacts climate change, barriers faced when implementing them. To identify studies, Scopus, PubMed Google Scholar databases were searched three times (from April October 2024, 21 April, 15 June, 9 September) years 2018 using PRISMA (Preferred Reporting Items Systematic Reviews Meta-Analyses) methodology. Specifically, search identified 471 articles, which specified inclusion exclusion criteria (secondary studies with criteria, being in English, etc.) met sixteen (16) studies. According findings reviewed, adaptation strategies focus structural changes, development training programs, surveillance systems, appropriate operational plans. The leader’s ability motivate employees achieve defined goals, continuous evaluation goals interventions, learning from previous disasters play an important role their implementation. Similarly, key policies mitigation include adoption sustainable practices, such as recycling cultural However, lack resources (human, material, financial) increased demand services make it difficult implement strategies. mainly theoretical nature confirmed other It suggested that further research should pursued, leading sustainability formulation policies.

Language: Английский

Citations

0
Scoping review e análise bibliométrica da produção científica sobre o estudo de coleções especiais: uma visão panorâmica do Google Scholar, Dimensions Free e Academia.edu DOI Open Access
Yelina Piedra Salomón, Carlos Manuel Valenciaga Díaz, Zoia Rivera

et al.

Encontros Bibli Revista Eletrônica de Biblioteconomia e Ciência da Informação, Journal Year: 2024, Volume and Issue: 29

Published: July 18, 2024

Objetivos: Sistematizar la literatura científica sobre el estudio de las colecciones documentos especiales disponibles en fuentes datos acceso abierto. Métodos: Se utiliza scoping review como herramienta metodológica. aplica framework SALSA y plantilla PRISMA- ScR. La revisión sistemática exploratoria Google Scholar, Dimensions Academia. Edu se complementa con un bibliométrico. conjunción ambas tributa a abordaje más holístico del objeto estudio. Resultados: análisis bibliométrico permitieron identificar características y/o rasgos distintivos dominio cuestión partir contenido científica. obtuvo una diversidad terminológica (homonimia, sinonimia, polisemia) existente torno denominación mismo documento/colección. El mapeo cobertura perfil temático determinó existencia amplia configuración temática génesis propuestas para dichas asociado frente que favorece aplicación Humanidades Digitales. Conclusiones: visualización los elementos, obtenidos revisión, revela evolución ascenso metodologías -desde CI - persiguen creación alternativas decodificación conforman utilizando nueva perspectiva ofrece bondades mayor inclusividad, homogeneidad responsabilidad social.

Citations

1
Tackling Pharmaceutical Pollution Along the Product Lifecycle: Roles and Responsibilities for Producers, Regulators and Prescribers DOI Creative Commons
Gillian Parker, Fiona A. Miller

Pharmacy, Journal Year: 2024, Volume and Issue: 12(6), P. 173 - 173

Published: Nov. 22, 2024

Pharmaceuticals produce considerable environmental harm. The industry’s resource-intensive nature, coupled with high energy costs for manufacturing and transportation, contribute to the “upstream” harms from greenhouse gas emissions ecosystem pollution, while factors such as overprescription, overuse, pharmaceutical waste “downstream” harms. Effectively addressing pollution requires an understanding of key roles responsibilities along product lifecycle. In this commentary, we argue that three actors—producers, regulators, prescribers—have unique interdependent address these issues. Producers market access regulators are upstream actors who can manage mitigate by both shifting manufacturing, business practices, regulatory requirements producing transparent, robust data on By contrast, prescribers downstream whose capacity reduce arises principally a “co-benefit” reducing inappropriate prescribing overuse. Potentially complicating prescriber’s role calls recommend “environmentally preferable medicines”. These continue increase, even sparsity transparent impact pharmaceuticals environment. Recognizing interdependencies among actors, that, rather than being ineffectual, draw needed attention critical responsibility prioritize production, reporting standards public transparency facilitate future efforts tackle pollution.

Language: Английский

Citations

1